Literature DB >> 16154051

Cabergoline: a safe, easy, cheap, and effective drug for prevention/treatment of ovarian hyperstimulation syndrome?

M Manno, F Tomei, E Marchesan, V Adamo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16154051     DOI： 10.1016/j.ejogrb.2005.01.009

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN： 0301-2115            Impact factor:   2.435


× No keyword cloud information.
  10 in total

Review 1.  Dopamine agonists for preventing ovarian hyperstimulation syndrome.

Authors:  Huilin Tang; Selma Mourad; Suo-Di Zhai; Roger J Hart
Journal:  Cochrane Database Syst Rev       Date:  2016-11-30

2.  Symptomatic unilateral pleural effusion: A rare presentation of ovarian hyperstimulation syndrome.

Authors:  Korula George; Tk Aleyamma; Ms Kamath; A Chandy; Ann M Mangalaraj; K Muthukumar; V Londhe
Journal:  J Hum Reprod Sci       Date:  2010-01

3.  Thiazolidinediones decrease vascular endothelial growth factor (VEGF) production by human luteinized granulosa cells in vitro.

Authors:  Divya K Shah; K M J Menon; Lourdes M Cabrera; Anjel Vahratian; Shahryar K Kavoussi; Dan I Lebovic
Journal:  Fertil Steril       Date:  2009-04-01       Impact factor: 7.329

Review 4.  VEGF antagonist for the prevention of ovarian hyperstimulation syndrome: Current status.

Authors:  Nikita Naredi; Pankaj Talwar; K Sandeep
Journal:  Med J Armed Forces India       Date:  2012-09-11

5.  Dopamine agonists for preventing ovarian hyperstimulation syndrome.

Authors:  Huilin Tang; Selma M Mourad; Aihua Wang; Suo-Di Zhai; Roger J Hart
Journal:  Cochrane Database Syst Rev       Date:  2021-04-14

6.  GnRH analogues in the prevention of ovarian hyperstimulation syndrome.

Authors:  Pilar Alama; Jose Bellver; Carmen Vidal; Juan Giles
Journal:  Int J Endocrinol Metab       Date:  2013-04-01

7.  Calcium gluconate infusion is as effective as the vascular endothelial growth factor antagonist cabergoline for the prevention of ovarian hyperstimulation syndrome.

Authors:  Nikita Naredi; Sandeep Karunakaran
Journal:  J Hum Reprod Sci       Date:  2013-10

8.  Treatment results of high dose cabergoline as an adjuvant therapy in six patients with established severe ovarian hyper stimulation syndrome.

Authors:  Nasrin Saharkhiz; Azadeh Akbari Sene; Saghar Salehpour; Maryam Tamimi; Masoumeh Vasheghani Farahani; Kourosh Sheibani
Journal:  Iran J Reprod Med       Date:  2014-10

9.  Severe ovarian hyperstimulation syndrome: Can we eliminate it through a multipronged approach?

Authors:  Nikita Naredi; S K Singh; Prasad Lele; N Nagraj
Journal:  Med J Armed Forces India       Date:  2017-06-19

10.  Short-term pharmacological suppression of the hyperprolactinemia of infertile hCG-overproducing female mice persistently restores their fertility.

Authors:  Laura D Ratner; Betina Gonzalez; Petteri Ahtiainen; Noelia P Di Giorgio; Matti Poutanen; Ricardo S Calandra; Ilpo T Huhtaniemi; Susana B Rulli
Journal:  Endocrinology       Date:  2012-11-01       Impact factor: 4.736
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.